Electrolytes Electrolytes are often overlooked on GLP-1, but they can make a noticeable difference in how you feel
Key drugs like semaglutide (Ozempic/Wegovy) and the dual agonist tirzepatide (Mounjaro/Zepbound) are at the forefront of a paradigm shift in treating metabolic disease
Prescribed online Free consult, 100% online, no doctor visit required Free & Private Delivery Free expediated shipping and discreet delivery Personalized support Customized and tailored care to find the right treatment Your questions, answered To contact customer service, email us at [email protected] or call us at 1-800-971-5773 (Mon-Fri, 9am-5pm EST)
Why GLP-1 Medications Stood Out in 2024 GLP-1 (Glucagon-Like Peptide-1) receptor agonists, such as Ozempic and Mounjaro , have long been some of the most effective tools for sustainable weight loss
New oral pill options include Amycretin, which contains GLP-1 and amylin, and Conveglipron, a new oral GLP-1 similar to Foundayo, which is currently in Phase 2-3 trials
